Pinku Mukherjee wears many hats.
She’s a leader in transforming how cancer is diagnosed and treated. She also has designed innovative approaches that more accurately detect breast cancer early, and she is developing targeted therapy and imaging for pancreatic, ovarian and colon cancers. Mukherjee’s groundbreaking cancer research has produced a U.S. patent and resulted in grants from the National Institutes of Health, the U.S. Department of Defense and the Susan G. Komen Foundation totaling more than $3.5 million as principal investigator and more than $500,000 as co-investigator.
The Irwin Belk Endowed Professor for Cancer Research, Mukherjee is the 2018 recipient of the First Citizens Bank Scholars Medal, UNC Charlotte’s most prestigious faculty award in recognition of excellence in research. She was honored at an awards ceremony on Wednesday, April 11, at the Harris Alumni Center at Johnson Glen. Since 1987, with the support from First Citizens Bank, the University annually presents this award to recognize and foster the advancement and diffusion of knowledge and creative endeavors. (Pictured from left to right: Provost Joan Lorden, Pinku Mukherjee, First Citizen's Kim Allred and Chancellor Dubois)
Mukherjee also is chair of the Department of Biological Sciences in the College of Liberal Arts & Sciences. “Pinku Mukherjee’s research not only has the potential to make possible early detection of cancers to allow early therapy but also to avoid unnecessary surgical procedures in people who do not have cancer but receive positive results in current tests that are notorious for their high rate of false positives,” said Mark Clemens, professor of biological sciences at UNC Charlotte.
In 2011, Mukherjee co-founded OncoTab Inc., a UNC Charlotte biotechnology spinoff company that is launching its first product (a simple blood test) that aids in the diagnosis of breast cancer for women in which a mammogram fails. She holds several patents for the development of a novel antibody that has applications in molecular diagnostics and anti-cancer therapeutics. OncoTab Inc. has won several awards including one from NCBiotech as well as the grand prize at 2016’s Charlotte Venture Challenge.
Mukherjee was the 2015 recipient of the O. Max Gardner Award, the highest faculty accolade given by the Board of Governors of the University of North Carolina.(Pictured: Pinku Mukherjee, and family at the awards ceremony)
“For 31 years, First Citizens and UNC Charlotte have come together to honor the outstanding achievements of an exceptional faculty member,” said Kim Allred, senior vice president at First Citizens Bank. “The spirit of the Scholars Medal truly reflects our bank’s ‘Forever First’ commitment to the people, businesses and communities we serve. It’s a great privilege for us to recognize Pinku Mukherjee for her immense contributions and the impact her work is having within the field of cancer research and most importantly, in the lives of people who face this illness.”